3. Riikonen R. A long-term follow-up study of 214 children with the
syndrome of infantile spasms. Neuropediatrics 1982;13:14-23.
4. Ohtahara S, Yamatogi Y. Evolution of seizures and EEG abnormalities
in childhood onset epilepsy. In: Wada JA, Ellingson RJ, eds. Handbook of
electroencephalography and clinical neurophysiology. 1st ed. Amsterdam:
Elsevier; 1990. p. 457-77.
5. Riikonen R. Long-term outcome of West syndrome: a study of adults
with a history of infantile spasms. Epilepsia 1996;37:367-72.
6. Holden KR, Clarke SL, Griesemer DA. Long-term outcomes of
conventional therapy for infantile spasms. Seizure 1997;6:201-5.
7. Hughes JR, Rechitsky I, Daaboul Y. Long-term changes inpatients with
hypsarrhythmia-infantile spasms: 505 patients, up to 43 years follow-up. Clin
Electroencephalogr 1997;28:1-15.
8. Ito M, Aiba H, Hashimoto K, Kuroki S, Tomiwa K, Okuno T, et al.
Low-dose ACTH therapy for West syndrome: initial effects and long-term
outcome. Neurology 2002;58:110-4.
9. Koo B, Hwang PA, Logan WJ. Infantile spasms: outcome and
prognostic factors of cryptogenic and symptomatic groups. Neurology
1993;43:2322-7.
10. Konishi Y, Yasujima M, Kuriyama M, Konishi K, Hayakawa K, Fujii Y,
et al. Magnetic resonance imaging in infantile spasms: effects of hormonal
therapy. Epilepsia 1992;33:304-9.
11. Volpe JJ. Brain injury in the premature infant: overview of clinical aspects, neuropathology, and pathogenesis. Semin Ped Neurol 1998;5:
135-51.
12. Okumura A, Hayakawa F, Kuno K, Watanabe K. Periventricular leukomalacia and West syndrome. Dev Med Child Neurol 1996;38:
13-8.
13. Riikonen R, Donner M. ACTH therapy in infantile spasms: side effects.
Arch Dis Child 1980;55:664-72.
14. Okuno T, Ito M, Konishi Y, Yoshioka M, Nakano Y. Cerebral atrophy
following ACTH therapy. J Comput Assist Tomogr 1980;4:20-3.
15. Satoh J, Takeshige H, Hara H, Fukuyama Y. Brain shrinkage and
subdural effusion associated with ACTH administration. Brain Dev 1982;
4:13-20.
16. Riikonenn R, Simell O, Ja ̈a ̈skela ̈inen J, Rapola J, Perheentupa J.
Disturbed calcium and phosphate homeostasis during treatment with ACTH
of infantile spasms. Arch Dis Child 1986;61:671-6.
17. Perheentupa J, Riikonenn R, Dunkel L, Simell O. Adrenocortical
hyporesponsiveness after treatment with ACTH of infantile spasms. Arch Dis
Child 1986;61:750-3.
18. Bobele GB, Ward KE, Bodensteiner JB. Hypertrophic cardiomyopathy
during corticotropin therapy for infantile spasms. A clinical and echocardiographic study. Am J Dis Child 1993;147:223-5.
19. Maeda H, Furune S, Nomura K, Kitou O, Ando Y, Negoro T, et al.
Decrease of N-acetylaspartate after ACTH therapy in patients with infantile
spasms. Neuropediatrics 1997;28:262-7.
20. Koo B. Vigabatrin in the treatment of infantile spasms. Pediatr Neurol
1999;20:106-10.
21. Mikati MA, Lepejian GA, Holmes GL. Medical treatment of patients
with infantile spasms. Clin Neuropharmacol 2002;25:61-70.
22. Yamamoto N, Watanabe K, Negoro T, Matsumoto A, Miyazaki S,
Kumagai T, et al. Long-term prognosis of tuberous sclerosis with epilepsy in
children. Brain Dev 1987;9:292-5.
